| Literature DB >> 18989165 |
Nataly Apollonsky1, Ashok Shende, Ihsane Ouansafi, Judith Brody, Mark Atlas, Banu Aygun.
Abstract
Transient myeloproliferative disorder (TMD) in newborns with Down syndrome (DS) has been well described. We report 4 newborns, 2 with DS and 2 without DS, who developed TMD. One newborn with DS developed multiorgan failure and died despite treatment with low-dose cytarabine. In 3 newborns, the TMD resolved spontaneously. Two of these patients, 1 with and 1 without DS developed leukemia on subsequent follow-up and were treated successfully. We reviewed the clinical and laboratory data on 14 non-DS infants with TMD reported in the literature. According to limited data, these patients are more likely to develop leukemia than DS patients, however their outcome is better.Entities:
Mesh:
Year: 2008 PMID: 18989165 DOI: 10.1097/MPH.0b013e31818a953e
Source DB: PubMed Journal: J Pediatr Hematol Oncol ISSN: 1077-4114 Impact factor: 1.289